Monitor gait and tremor remotely
- Trial ID
- NCT06573762
- Official Title
- Remote Monitoring Using Commercially Available Activity Trackers and Computer Vision Provides a Holistic, Low-cost Assessment of Parkinson's Disease Symptoms
- Goal
- Monitor gait and tremor remotely
- Status
- RECRUITING
- Sponsor
- Jacob E. Simmering
- Study Type
- OBSERVATIONAL
- Enrollment
- 120 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to see if consumer activity trackers plus computer vision can give a holistic, low-cost picture of Parkinson's motor symptoms over time, capturing real-world changes that clinic visits often miss. Participants wear a Fitbit that records steps, activity, sleep and heart rate, and submit short videos that are analyzed by computer vision to quantify tremor, slowness, and gait; combining these objective measures could make symptom tracking more continuous and precise. There is no drug or device treatment here, the study only collects data remotely to evaluate how well these tools reflect Parkinson's signs. They are enrolling people aged 50 to 110 in two groups, either newly referred with possible Parkinson's who have not been previously diagnosed, or clinic patients diagnosed within the past 6 months; exclusions include being bed- or wheelchair-bound, non-English speakers, prisoners, inability to consent, or not having a phone that supports the Fitbit app.
Locations
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see if consumer activity trackers plus computer vision can give a holistic, low-cost picture of Parkinson's motor symptoms over time, capturing real-world changes that clinic visits often miss. Participants wear a Fitbit that records steps, activity, sleep and heart rate, and submit short videos that are analyzed by computer vision to quantify tremor, slowness, and gait; combining these objective measures could make symptom tracking more continuous and precise. There is no drug or device treatment here, the study only collects data remotely to evaluate how well these tools reflect Parkinson's signs. They are enrolling people aged 50 to 110 in two groups, either newly referred with possible Parkinson's who have not been previously diagnosed, or clinic patients diagnosed within the past 6 months; exclusions include being bed- or wheelchair-bound, non-English speakers, prisoners, inability to consent, or not having a phone that supports the Fitbit app.
- Who can participate?
- Participants must be between 50 Years and 110 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.